121 related articles for article (PubMed ID: 21306606)
1. Overexpression of LCMR1 is significantly associated with clinical stage in human NSCLC.
Chen L; Liang Z; Tian Q; Li C; Ma X; Zhang Y; Yang Z; Wang P; Li Y
J Exp Clin Cancer Res; 2011 Feb; 30(1):18. PubMed ID: 21306606
[TBL] [Abstract][Full Text] [Related]
2. LCMR1 interacts with DEK to suppress apoptosis in lung cancer cells.
Xu Y; Liang Z; Li C; Yang Z; Chen L
Mol Med Rep; 2017 Oct; 16(4):4159-4164. PubMed ID: 28765911
[TBL] [Abstract][Full Text] [Related]
3. Suppression of lung cancer metastasis-related protein 1 promotes apoptosis in lung cancer cells.
Xu Y; Li C; Tian Q; Li Y; Yang Z; Liang Z; Chen L
Int J Mol Med; 2012 Dec; 30(6):1481-6. PubMed ID: 23076562
[TBL] [Abstract][Full Text] [Related]
4. LCMR1 Promotes Large-Cell Lung Cancer Proliferation and Metastasis by Downregulating HLA-Encoding Genes.
Liu L; Li C; Wu Z; Li Y; Yu H; Li T; Wang Y; Zhao W; Chen L
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001705
[TBL] [Abstract][Full Text] [Related]
5. MED12 exerts an emerging role in actin-mediated cytokinesis via LIMK2/cofilin pathway in NSCLC.
Xu M; Wang F; Li G; Wang X; Fang X; Jin H; Chen Z; Zhang J; Fu L
Mol Cancer; 2019 May; 18(1):93. PubMed ID: 31072327
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of PAI-RBP1, C1orf142, and COTL1 in non-small cell lung cancer cell lines with different tumor metastatic potential.
Sun W; Guo C; Meng X; Yu Y; Jin Y; Tong D; Geng J; Huang Q; Qi J; Liu A; Guan R; Xu L; Sun D; Ji W; Liu P; Liu F; Sun H; Ji G; Fu S; Bai J
J Investig Med; 2012 Apr; 60(4):689-94. PubMed ID: 22373659
[TBL] [Abstract][Full Text] [Related]
7. Suppression of lung cancer metastasis-related protein 1 (LCMR1) inhibits the growth of colorectal cancer cells.
Ji-Fu E; Xing JJ; Hao LQ; Fu CG
Mol Biol Rep; 2012 Apr; 39(4):3675-81. PubMed ID: 21732059
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
10. MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer.
Yuan K; Chen Z; Li W; Gao CE; Li G; Guo G; Yang Y; Ai Y; Wu L; Zhang M
Arch Med Res; 2015 Nov; 46(8):635-41. PubMed ID: 26656665
[TBL] [Abstract][Full Text] [Related]
11. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
[TBL] [Abstract][Full Text] [Related]
12. Expression of placental growth factor gene in lung cancer.
Woo IS; Park MJ; Byun JH; Hong YS; Lee KS; Park YS; Lee JA; Park YI; Ahn HK
Tumour Biol; 2004; 25(1-2):1-6. PubMed ID: 15192305
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
Lung Cancer; 2015 Feb; 87(2):107-16. PubMed ID: 25564397
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
[TBL] [Abstract][Full Text] [Related]
15. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
[TBL] [Abstract][Full Text] [Related]
16. [Expression of endoglin in human non-small cell lung cancer and its clinical significance].
Li M; Lu S; Liu X; Zhao J; Zhang H; Ling C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):581-4. PubMed ID: 23746240
[TBL] [Abstract][Full Text] [Related]
17. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
Chen H; Yang T; Lei Z; Wang L; Yang H; Tong X; Yang WT; Zhao J; Gu Y; Chen Y; Zhang HT
Lung Cancer; 2015 Oct; 90(1):32-40. PubMed ID: 26238425
[TBL] [Abstract][Full Text] [Related]
18. LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.
Liu Y; Xing Y; Wang H; Yan S; Wang X; Cai L
Thorac Cancer; 2018 Dec; 9(12):1725-1732. PubMed ID: 30273983
[TBL] [Abstract][Full Text] [Related]
19. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
[TBL] [Abstract][Full Text] [Related]
20. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
